Use of Human Embryonic Stem Cells (hESCs) in the Treatment of Glaucoma
International Journal of Medical and Pharmaceutical Case Reports · pp. 72–76 · Published 25 May 2015
10.9734/IJMPCR/2015/18440Abstract
Glaucoma is a degenerative, optic neuropathy that results in damage to the optic nerve due to increased intraocular pressure (IOP). IOP can be influenced by hypertension, body mass index, atherosclerotic disease and diabetes. Cell based therapies play an important role in treating eye diseases, especially (irreversible loss of cells) due to glaucoma. We used human embryonic stem cell (hESC) therapy in two patients with glaucoma. hESCs are derived from a patented technology and are in use since the last 13 years. After the therapy, patients showed signs of improvement in their sight such as in peripheral vision, as well as in cognitive abilities like concentration and speech.
Cited by 0
No indexed citations yet.
Related research
- Anxiety and Visual Field Assessment Reliability in Glaucoma Patients — shares topic coverage
- Evaluation of Antioxidants, and Haematological Indices in Glaucoma Patients: A Case Study of Bayelsa State, Nigeria — shares topic coverage
- Aniseikonia- Easy to Understand — shares topic coverage
- Health Workers Awareness and Knowledge of Glaucoma in Tertiary Hospital in Birnin Kebbi, Nigeria — shares topic coverage
- Family History of Glaucoma: A Predictive Factor? — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.